Literature DB >> 15534099

X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.

Robert L Camp1, Marisa Dolled-Filhart, David L Rimm.   

Abstract

The ability to parse tumors into subsets based on biomarker expression has many clinical applications; however, there is no global way to visualize the best cut-points for creating such divisions. We have developed a graphical method, the X-tile plot that illustrates the presence of substantial tumor subpopulations and shows the robustness of the relationship between a biomarker and outcome by construction of a two dimensional projection of every possible subpopulation. We validate X-tile plots by examining the expression of several established prognostic markers (human epidermal growth factor receptor-2, estrogen receptor, p53 expression, patient age, tumor size, and node number) in cohorts of breast cancer patients and show how X-tile plots of each marker predict population subsets rooted in the known biology of their expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15534099     DOI: 10.1158/1078-0432.CCR-04-0713

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  1314 in total

1.  Unfavorable effect of small tumor size on cause-specific survival in stage IIA colon cancer, a SEER-based study.

Authors:  Yuwei Wang; Changhua Zhuo; Debing Shi; Hongtu Zheng; Ye Xu; Weilie Gu; Sanjun Cai; Guoxiang Cai
Journal:  Int J Colorectal Dis       Date:  2014-11-13       Impact factor: 2.571

2.  Bortezomib stabilizes mitotic cyclins and prevents cell cycle progression via inhibition of UBE2C in colorectal carcinoma.

Authors:  Prashant Bavi; Shahab Uddin; Maqbool Ahmed; Zeenath Jehan; Rong Bu; Jehad Abubaker; Mehar Sultana; Nasser Al-Sanea; Alaa Abduljabbar; Luai H Ashari; Samar Alhomoud; Fouad Al-Dayel; Sarita Prabhakaran; Azhar R Hussain; Khawla S Al-Kuraya
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

3.  CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis.

Authors:  Gong Yang; Daniel G Rosen; Guangzhi Liu; Fan Yang; Xiaoqing Guo; Xue Xiao; Fengxia Xue; Imelda Mercado-Uribe; Jiaoti Huang; Sue-Hwa Lin; Gordon B Mills; Jinsong Liu
Journal:  Clin Cancer Res       Date:  2010-05-26       Impact factor: 12.531

4.  Expression of Jagged1 predicts postoperative clinical outcome of patients with gastric cancer.

Authors:  Hao Liu; Heng Zhang; Zhenbin Shen; Xuefei Wang; Zhenglin Wang; Jiejie Xu; Yihong Sun
Journal:  Int J Clin Exp Med       Date:  2015-09-15

5.  Lower MGMT expression predicts better prognosis in proneural-like glioblastoma.

Authors:  Zhi-Cheng He; Yi-Fang Ping; Sen-Lin Xu; Yong Lin; Shi-Cang Yu; Hsiang-Fu Kung; Xiu-Wu Bian
Journal:  Int J Clin Exp Med       Date:  2015-11-15

6.  Expression of the calpain system is associated with poor clinical outcome in gastro-oesophageal adenocarcinomas.

Authors:  Sarah J Storr; Xuan Pu; Jillian Davis; Dileep Lobo; Alex M Reece-Smith; Simon L Parsons; Srinivasan Madhusudan; Stewart G Martin
Journal:  J Gastroenterol       Date:  2013-01-19       Impact factor: 7.527

7.  Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma.

Authors:  Spyridon Christodoulou; Dimitra K Alexopoulou; Christos K Kontos; Andreas Scorilas; Iordanis N Papadopoulos
Journal:  Tumour Biol       Date:  2014-01-16

8.  High FUT3 expression is a marker of lower overall survival of breast cancer patients.

Authors:  Jessica Catarine Frutuoso do Nascimento; Eduardo Isidoro Carneiro Beltrão; Cíntia Renata Costa Rocha
Journal:  Glycoconj J       Date:  2020-02-15       Impact factor: 2.916

9.  Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines.

Authors:  Ivan V Litvinov; Brendan Cordeiro; Simon Fredholm; Niels Ødum; Hanieh Zargham; Yuanshen Huang; Youwen Zhou; Kevin Pehr; Thomas S Kupper; Anders Woetmann; Denis Sasseville
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

10.  Expression of Helios in gastric tumor cells predicts better survival in gastric cancer patients.

Authors:  Wei-Ming Chen; Cheng-Shyong Wu; Jing-Lan Liu; Chia-Ming Yeh; Libby Tseng; Hao-Chun Huang; Pey-Jium Chang; Shu-Fen Wu
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-30       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.